CeriBell Stock
CeriBell, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Xingjuan Chao
- Employees
- 327
- Market cap
- $961 M
- IPO
- 11/10/2024
- Web
- ceribell.com
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG…
CeriBell stock: price history
1D
-9.4%
1W
+6.0%
1M
+2.2%
6M
+18.2%
YTD
+14.2%
1Y
+92.8%
2Y
-5.3%
5Y
–
10Y
–
Next earnings date
Next earnings date
03/11/2026 (in 17 days)
Volatility around earnings
~18% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Business model & megatrends
Classification runs nightly; this stock doesn't have one yet.
Ask the agents about CeriBell
Analyst assessment of CeriBell
PRICE TARGET LOW
US$26.00
CONSENSUS
US$27.50
MEDIAN
US$27.50
PRICE TARGET HIGH
US$29.00
0
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 02/10/2026
CeriBell stock metrics
P/E
-14.23
P/B
7.42
EV/EBITDA
-15.08
RETURN ON EQUITY
-15.0%
NET MARGIN
-68.6%
DEBT/EQUITY
0.17
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
66.6%
FLOAT SHARES
25,569,256
AVG. DAILY VOLUME (30D)
392,114
Insider transactions (SEC)
Woo Raymond
Woo Raymond
Woo Raymond
Chao Xingjuan
Blumberg Scott
Institutional holders
Comparable stocks
Frequently asked questions about CeriBell stock
What does CeriBell do?
CeriBell, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Xingjuan Chao, the company employs around 327 people.
The IPO was on 11/10/2024; the stock trades on NASDAQ under the ticker CBLL.
What do analysts say about CeriBell stock?
4 analysts rate the stock, the consensus is Buy (as of 02/10/2026).
The average price target is US$27.50, ranging from US$26.00 to US$29.00, with a median of US$27.50.
This is an external assessment, not a statement by Market Jury.
When does CeriBell report next?
The next earnings date is 03/11/2026.
Around past earnings, price swings were roughly 18% stronger than usual.
Does CeriBell pay a dividend?
No, CeriBell currently does not pay a dividend.
Which stocks are comparable to CeriBell?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get CeriBell stock analyzed?
Clicking "Analyze stock" lets five strategies assess CeriBell against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.